Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $7,745 | 525 | 99.5% |
| Education | $41.64 | 5 | 0.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $1,889 | 148 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $1,484 | 96 | $0 (2024) |
| PFIZER INC. | $550.72 | 38 | $0 (2024) |
| Merck Sharp & Dohme Corporation | $469.85 | 31 | $0 (2021) |
| GlaxoSmithKline, LLC. | $437.21 | 26 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $397.97 | 27 | $0 (2021) |
| Lilly USA, LLC | $396.97 | 28 | $0 (2024) |
| Amgen Inc. | $372.43 | 23 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $277.43 | 19 | $0 (2019) |
| Astellas Pharma US Inc | $248.45 | 16 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $411.82 | 22 | AstraZeneca Pharmaceuticals LP ($112.71) |
| 2023 | $501.28 | 30 | Novo Nordisk Inc ($201.95) |
| 2022 | $583.22 | 35 | Novo Nordisk Inc ($175.64) |
| 2021 | $990.31 | 62 | Novo Nordisk Inc ($297.96) |
| 2020 | $1,114 | 72 | AstraZeneca Pharmaceuticals LP ($319.59) |
| 2019 | $1,131 | 78 | Novo Nordisk Inc ($237.36) |
| 2018 | $1,254 | 89 | AstraZeneca Pharmaceuticals LP ($269.68) |
| 2017 | $1,802 | 142 | Novo Nordisk Inc ($410.69) |
All Payment Transactions
530 individual payment records from CMS Open Payments — Page 1 of 22
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/21/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $22.08 | General |
| Category: Diabetes | ||||||
| 11/19/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $18.62 | General |
| Category: Respiratory | ||||||
| 09/30/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $17.25 | General |
| Category: Respiratory | ||||||
| 09/24/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $17.68 | General |
| Category: Diabetes | ||||||
| 09/12/2024 | Novo Nordisk Inc | Rybelsus (Drug) | Food and Beverage | In-kind items and services | $17.15 | General |
| Category: Diabetes | ||||||
| 08/20/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $20.52 | General |
| Category: Inflammation | ||||||
| 08/13/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $19.97 | General |
| Category: Respiratory | ||||||
| 08/08/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $19.17 | General |
| Category: RESPIRATORY | ||||||
| 08/06/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $15.34 | General |
| Category: Diabetes | ||||||
| 06/28/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $19.15 | General |
| Category: Diabetes | ||||||
| 06/03/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $20.27 | General |
| Category: Diabetes | ||||||
| 05/28/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $20.53 | General |
| Category: Inflammation | ||||||
| 05/09/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $15.10 | General |
| Category: Diabetes | ||||||
| 05/07/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $19.40 | General |
| Category: Respiratory | ||||||
| 04/26/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $17.77 | General |
| Category: RESPIRATORY | ||||||
| 04/23/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $19.00 | General |
| Category: Oncology | ||||||
| 04/22/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $13.47 | General |
| Category: GASTROENTEROLOGY | ||||||
| 04/16/2024 | PFIZER INC. | PREMARIN (Drug), ESTRING, DUAVEE | Food and Beverage | In-kind items and services | $20.96 | General |
| Category: WOMENS HEALTH | ||||||
| 04/11/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $17.88 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 03/08/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $19.59 | General |
| Category: Respiratory | ||||||
| 02/12/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug), SHINGRIX | Food and Beverage | In-kind items and services | $21.21 | General |
| Category: RESPIRATORY | ||||||
| 02/09/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $19.71 | General |
| Category: Biological | ||||||
| 12/06/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY, SHINGRIX | Food and Beverage | In-kind items and services | $15.33 | General |
| Category: RESPIRATORY | ||||||
| 12/05/2023 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $5.01 | General |
| Category: Obesity | ||||||
| 11/21/2023 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $16.28 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 16 | 1,647 | 3,096 | $305,290 | $154,463 |
| 2022 | 18 | 2,098 | 3,872 | $384,123 | $199,642 |
| 2021 | 19 | 2,510 | 4,105 | $405,830 | $225,192 |
| 2020 | 16 | 2,357 | 3,603 | $367,532 | $168,004 |
All Medicare Procedures & Services
69 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 362 | 1,179 | $188,640 | $90,164 | 47.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 256 | 256 | $51,200 | $30,503 | 59.6% |
| 99495 | Transitional care management services for problem of at least moderate complexity | Office | 2023 | 26 | 35 | $7,000 | $5,105 | 72.9% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 266 | 266 | $6,650 | $4,463 | 67.1% |
| 83037 | Hemoglobin a1c level, by device for home use | Office | 2023 | 209 | 409 | $11,443 | $3,894 | 34.0% |
| 99457 | Management using the results of remote vital sign monitoring per calendar month, first 20 minutes | Office | 2023 | 20 | 120 | $7,440 | $3,843 | 51.7% |
| 90756 | Influenza vaccine, quadrivalent derived from cell cultures | Office | 2023 | 108 | 109 | $3,815 | $3,447 | 90.4% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 104 | 105 | $4,043 | $2,993 | 74.0% |
| 99454 | Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days | Office | 2023 | 19 | 83 | $5,976 | $2,518 | 42.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 36 | 45 | $4,950 | $2,385 | 48.2% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2023 | 29 | 56 | $3,920 | $2,077 | 53.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 16 | 16 | $4,000 | $1,572 | 39.3% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 81 | 126 | $4,536 | $1,227 | 27.1% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 79 | 229 | $1,145 | $182.38 | 15.9% |
| 81002 | Urinalysis, manual test | Office | 2023 | 21 | 23 | $345.00 | $78.43 | 22.7% |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | Office | 2023 | 15 | 39 | $187.20 | $12.31 | 6.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 422 | 1,365 | $218,490 | $106,675 | 48.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 318 | 318 | $63,600 | $39,050 | 61.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 145 | 205 | $22,550 | $11,799 | 52.3% |
| 99457 | Management using the results of remote vital sign monitoring per calendar month, first 20 minutes | Office | 2022 | 30 | 194 | $12,028 | $6,817 | 56.7% |
| G0444 | Annual depression screening, 15 minutes | Office | 2022 | 325 | 325 | $8,125 | $5,529 | 68.1% |
| 99454 | Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days | Office | 2022 | 27 | 145 | $10,440 | $5,304 | 50.8% |
| 83037 | Hemoglobin a1c level, by device for home use | Office | 2022 | 231 | 481 | $13,468 | $4,586 | 34.0% |
| 99495 | Transitional care management services for problem of moderate complexity | Office | 2022 | 27 | 28 | $5,600 | $4,207 | 75.1% |
| 90756 | Influenza vaccine, quadrivalent derived from cell cultures | Office | 2022 | 134 | 136 | $4,760 | $4,066 | 85.4% |
About Dr. Iqbal Saeed, M.D
Dr. Iqbal Saeed, M.D is a Internal Medicine healthcare provider based in Huntsville, Alabama. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/09/2006. The National Provider Identifier (NPI) number assigned to this provider is 1235170622.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Iqbal Saeed, M.D has received a total of $7,786 in payments from pharmaceutical and medical device companies, with $411.82 received in 2024. These payments were reported across 530 transactions from 24 companies. The most common payment nature is "Food and Beverage" ($7,745).
As a Medicare-enrolled provider, Saeed has provided services to 8,612 Medicare beneficiaries, totaling 14,676 services with total Medicare billing of $747,302. Data is available for 4 years (2020–2023), covering 69 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location Huntsville, AL
- Active Since 06/09/2006
- Last Updated 09/18/2012
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1235170622
Products in Payments
- Ozempic (Drug) $905.98
- FARXIGA (Drug) $619.71
- JANUVIA (Drug) $434.69
- Victoza (Drug) $425.15
- TRELEGY ELLIPTA (Drug) $332.07
- SYMBICORT (Drug) $313.08
- Rybelsus (Drug) $279.35
- TRULICITY (Drug) $265.90
- TRADJENTA (Drug) $254.92
- XARELTO (Drug) $244.77
- Livalo (Drug) $215.67
- CHANTIX (Drug) $199.34
- ENTRESTO (Drug) $181.80
- BEVESPI AEROSPHERE (Drug) $180.30
- Vascepa (Drug) $180.01
- TOUJEO (Drug) $151.93
- SOLIQUA (Drug) $146.31
- Myrbetriq (Drug) $145.85
- Tresiba (Drug) $114.91
- BREZTRI (Drug) $110.19
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Huntsville
Dr. James Roy, M.d., Ph.d, M.D., PH.D
Internal Medicine — Payments: $849,153
Dr. Gaurav Aggarwala, M.d, M.D
Internal Medicine — Payments: $115,539
Dr. Kaushik Jain, Do, DO
Internal Medicine — Payments: $61,725
Jeffery Allison, M.d, M.D
Internal Medicine — Payments: $33,217
Ehab El-Bahesh, M.d, M.D
Internal Medicine — Payments: $31,265
Dr. Kun Chen, Md, Phd, MD, PHD
Internal Medicine — Payments: $24,543